These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 32390303

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling.
    Liu Y, Qin Z, Yang K, Liu R, Xu Y.
    Oncol Rep; 2017 Mar; 37(3):1521-1528. PubMed ID: 28098905
    [Abstract] [Full Text] [Related]

  • 25. BDNF activates TrkB/PLCγ1 signaling pathway to promote proliferation and invasion of ovarian cancer cells through inhibition of apoptosis.
    Xu Y, Jiang WG, Wang HC, Martin T, Zeng YX, Zhang J, Qi YS.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5093-5100. PubMed ID: 31298409
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    Tsai YF, Tseng LM, Hsu CY, Yang MH, Chiu JH, Shyr YM.
    PLoS One; 2017 Jun; 12(6):e0178173. PubMed ID: 28604807
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S, Duan YX, Zhou Q, Wang Y, Lu Q.
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High TrkB expression levels are associated with poor prognosis and EMT induction in colorectal cancer cells.
    Fujikawa H, Tanaka K, Toiyama Y, Saigusa S, Inoue Y, Uchida K, Kusunoki M.
    J Gastroenterol; 2012 Jul; 47(7):775-84. PubMed ID: 22361863
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.
    Zhao Y, Cai C, Zhang M, Shi L, Wang J, Zhang H, Ma P, Li S.
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2013-2023. PubMed ID: 33772606
    [Abstract] [Full Text] [Related]

  • 35. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
    Jia J, Zhang W, Liu JY, Chen G, Liu H, Zhong HY, Liu B, Cai Y, Zhang JL, Zhao YF.
    PLoS One; 2012 Jul; 7(12):e51549. PubMed ID: 23272116
    [Abstract] [Full Text] [Related]

  • 36. Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.
    Dudás J, Riml A, Tuertscher R, Pritz C, Steinbichler TB, Schartinger VH, Sprung S, Glueckert R, Schrott-Fischer A, Johnson Chacko L, Riechelmann H.
    Int J Mol Sci; 2019 Jan 11; 20(2):. PubMed ID: 30641914
    [Abstract] [Full Text] [Related]

  • 37. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases.
    Choy C, Ansari KI, Neman J, Hsu S, Duenas MJ, Li H, Vaidehi N, Jandial R.
    Breast Cancer Res; 2017 Apr 26; 19(1):51. PubMed ID: 28446206
    [Abstract] [Full Text] [Related]

  • 38. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
    Lee E, Wang J, Yumoto K, Jung Y, Cackowski FC, Decker AM, Li Y, Franceschi RT, Pienta KJ, Taichman RS.
    Neoplasia; 2016 Sep 26; 18(9):553-66. PubMed ID: 27659015
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X, Ning J, Geng Q, Wang C, Hu Y, Li M, Niu W, Li E, Wu Y.
    Oncotarget; 2017 Jun 13; 8(24):38825-38840. PubMed ID: 28418915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.